Dr Cindy Lee Bredefeld, DO | |
1300 Franklin Ave, Suite Ml-6, Garden City, NY 11530-1886 | |
(516) 663-3511 | |
(516) 663-4780 |
Full Name | Dr Cindy Lee Bredefeld |
---|---|
Gender | Female |
Speciality | Endocrinology |
Experience | 20 Years |
Location | 1300 Franklin Ave, Garden City, New York |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1902119381 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 257899 (New York) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
New York University Langone Medical Center | New york, NY | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
New York University | 1355232422 | 4431 |
News Archive
Hyaluronic acid (HA) fillers are a popular treatment for facial lines and wrinkles, but early degradation of fillers may limit how long their effects last. Experimental evidence supports a simple technique for prolonging the effects of HA dermal fillers: using them together with botulinum toxin, reports a paper in the January issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS).
Although neurofibromatosis (NF) is not commonly discussed, it affects more than 2 million people worldwide.
Results from the combined analysis of two European Phase II trials were presented today at the 3rd European Lung Cancer Conference in Geneva, Switzerland. The VeriStrat retrospective analysis was performed on serum samples from advanced non-squamous non-small cell lung cancer (NSCLC) patients treated with the combination therapy bevacizumab plus erlotinib.
Since the pandemic hit, researchers have been uncovering ways COVID-19 impacts other parts of the body, besides the lungs.
PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced the introduction of a wide range of new tools to improve the speed and effectiveness of life sciences research.
› Verified 3 days ago
Entity Name | New York University |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1285826438 PECOS PAC ID: 1355232422 Enrollment ID: O20090822000026 |
News Archive
Hyaluronic acid (HA) fillers are a popular treatment for facial lines and wrinkles, but early degradation of fillers may limit how long their effects last. Experimental evidence supports a simple technique for prolonging the effects of HA dermal fillers: using them together with botulinum toxin, reports a paper in the January issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS).
Although neurofibromatosis (NF) is not commonly discussed, it affects more than 2 million people worldwide.
Results from the combined analysis of two European Phase II trials were presented today at the 3rd European Lung Cancer Conference in Geneva, Switzerland. The VeriStrat retrospective analysis was performed on serum samples from advanced non-squamous non-small cell lung cancer (NSCLC) patients treated with the combination therapy bevacizumab plus erlotinib.
Since the pandemic hit, researchers have been uncovering ways COVID-19 impacts other parts of the body, besides the lungs.
PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced the introduction of a wide range of new tools to improve the speed and effectiveness of life sciences research.
› Verified 3 days ago
Entity Name | Winthrop Community Medical Affiliates Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1457873077 PECOS PAC ID: 5698092385 Enrollment ID: O20150317001669 |
News Archive
Hyaluronic acid (HA) fillers are a popular treatment for facial lines and wrinkles, but early degradation of fillers may limit how long their effects last. Experimental evidence supports a simple technique for prolonging the effects of HA dermal fillers: using them together with botulinum toxin, reports a paper in the January issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS).
Although neurofibromatosis (NF) is not commonly discussed, it affects more than 2 million people worldwide.
Results from the combined analysis of two European Phase II trials were presented today at the 3rd European Lung Cancer Conference in Geneva, Switzerland. The VeriStrat retrospective analysis was performed on serum samples from advanced non-squamous non-small cell lung cancer (NSCLC) patients treated with the combination therapy bevacizumab plus erlotinib.
Since the pandemic hit, researchers have been uncovering ways COVID-19 impacts other parts of the body, besides the lungs.
PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced the introduction of a wide range of new tools to improve the speed and effectiveness of life sciences research.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Cindy Lee Bredefeld, DO 1300 Franklin Ave, Suite Ml-6, Garden City, NY 11530-1886 Ph: (516) 663-3511 | Dr Cindy Lee Bredefeld, DO 1300 Franklin Ave, Suite Ml-6, Garden City, NY 11530-1886 Ph: (516) 663-3511 |
News Archive
Hyaluronic acid (HA) fillers are a popular treatment for facial lines and wrinkles, but early degradation of fillers may limit how long their effects last. Experimental evidence supports a simple technique for prolonging the effects of HA dermal fillers: using them together with botulinum toxin, reports a paper in the January issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS).
Although neurofibromatosis (NF) is not commonly discussed, it affects more than 2 million people worldwide.
Results from the combined analysis of two European Phase II trials were presented today at the 3rd European Lung Cancer Conference in Geneva, Switzerland. The VeriStrat retrospective analysis was performed on serum samples from advanced non-squamous non-small cell lung cancer (NSCLC) patients treated with the combination therapy bevacizumab plus erlotinib.
Since the pandemic hit, researchers have been uncovering ways COVID-19 impacts other parts of the body, besides the lungs.
PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced the introduction of a wide range of new tools to improve the speed and effectiveness of life sciences research.
› Verified 3 days ago
Dr. Daniel S Donohue, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 975 Stewart Ave, Garden City, NY 11530 Phone: 516-222-8650 Fax: 516-745-5476 | |
Jung H Youn, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1000 Franklin Ave, Suite 300, Garden City, NY 11530 Phone: 516-248-6868 Fax: 516-248-6841 | |
Dr. Miguel Cima, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 877 Stewart Ave, Suite 28, Garden City, NY 11530 Phone: 516-222-1000 Fax: 516-222-1017 | |
Dr. Philip Stein, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 975 Stewart Ave, Garden City, NY 11530 Phone: 516-222-8630 Fax: 516-745-5476 | |
Dr. Kinga Marta Riccobono, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1001 Franklin Ave, Suite 106, Garden City, NY 11530 Phone: 516-240-8700 Fax: 516-240-8787 | |
Dr. Robert J Bonasera, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1205 Franklin Ave Ste 150, Garden City, NY 11530 Phone: 516-222-0067 Fax: 516-222-0071 | |
Dr. Richard Keith Schwartz, DO Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1401 Franklin Ave, Garden City, NY 11530 Phone: 516-877-2626 Fax: 516-877-0945 |